National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Adult Hodgkin Lymphoma Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 03/10/2009



Purpose of This PDQ Summary






General Information About Adult Hodgkin Lymphoma






Cellular Classification of Adult Hodgkin Lymphoma






Stage Information for Adult Hodgkin Lymphoma






Treatment Option Overview






Early Favorable Hodgkin Lymphoma






Early Unfavorable Hodgkin Lymphoma






Advanced Favorable Hodgkin Lymphoma






Advanced Unfavorable Hodgkin Lymphoma






Recurrent Adult Hodgkin Lymphoma






Hodgkin Lymphoma During Pregnancy






Get More Information From NCI






Changes to This Summary (03/10/2009)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Changes to This Summary (03/10/2009)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Stage Information for Adult Hodgkin Lymphoma

Added text about a prospective trial of previously untreated patients with advanced-stage disease and residual abnormalities in whom a BEACOPP-based therapy and positron emission tomography were used but for which overall survival data are awaited (cited Kobe et al. as reference 10).

Recurrent Adult Hodgkin Lymphoma

Added text to update statistics on the disease-free survival rate (cited Gopal et al. as reference 30).

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov